WHITE PLAINS, N.Y. and TWINSBURG, Ohio, Nov. 30 /PRNewswire/ -- Collaborative research efforts on the part of CAD Sciences, an emerging medical technologies company, and Hitachi Medical Systems America, Inc. ("HMSA"), a leader in Open MRI technology in the U.S. since 1989, has produced an optimized MR image acquisition protocol that establishes the compatibility of CAD Sciences' advanced fTP(TM) pharmacokinetic analysis algorithm and HMSA's Altaire(R) high-field Open MRI system. The coupling of these two technologies will afford patients the opportunity to have comprehensive, high-quality breast MR imaging and state-of-the-art post processing algorithms that streamline diagnosis.
CAD Sciences' and Hitachi's first-time collaboration effort has worked to incorporate the physician's dual need for an open MRI system designed with excellent patient accessibility and comfort, and an image post-processing tool for streamlined diagnosis and workflow for the breast radiology practice. With the advent of high-quality, patient-friendly open MRI systems such as Altaire, and the innovative approach of a four compartment pharmacokinetic analysis algorithm, Hitachi and CAD Sciences are setting a new standard for cost-efficient, comprehensive breast imaging that allows patients to benefit from an open scanning environment in conjunction with advanced image processing.
"It simply isn't possible to produce meaningful lesion characterization using the three-time-point technologies currently offered by other CAD companies. The user of an MRI system, by utilizing CAD Sciences' advanced fTP(TM) algorithm, benefits from a more robust analysis of all available time points contained in an MR data set," said Andreas Muehler, President of CAD Sciences.
Ray Joslin, CAD Sciences' CEO added, "The collaboration between CAD Sciences and Hitachi underscores the natural synergy that exists between these two technology leaders in their respective fields, and has led to the creation of a product solution that is optimized for the radiologist who wishes to provide patients with a comfortable and open imaging environment in conjunction with superior image processing capability to facilitate and streamline lesion diagnosis. This collaboration seeks to increase the options available to both clinicians and patients in the collective fight against breast cancer. fTP(TM) is the only commercially available product of its kind that calculates vascular permeability (PERM) and extra-cellular volume fraction (EVF) values, widely known to be key differentiators of cancer, for all pixels in contrast-enhanced MRI studies."
Shawn Etheridge, Marketing Manager, Magnetic Resonance, HMSA notes, "The benefit of our collaboration with CAD Sciences is that Hitachi Altaire users can now implement a very broad based approach to breast cancer diagnosis, combining Altaire's excellent breast imaging capability and intervention supporting Breast coil with Breast MRI CAD."
Altaire with VOSI(TM) technology is Hitachi's most advanced Open MR system. VOSI technology is the embodiment of Hitachi's attention to each aspect of the imaging system's specification, design and manufacture. Altaire combines high-field performance with the patient comfort of Open MR, offering a no-compromise imaging platform.
About CAD Sciences:
Based in White Plains, NY, CAD Sciences is a privately-held company which designs and internationally distributes certain intellectual property in CAD (Computer Assisted Diagnosis) and MRA (Magnetic Resonance Angiography) software. The Company's Server2(TM) and WorkSpace(TM) software platforms facilitate the analysis, interventional planning and reporting of breast and prostate MRI. Server2(TM) and WorkSpace(TM) are trademarks of CAD Sciences.
The Company's other software platform, "VTRAC," is a solution for MRA Imaging with fully automated arterial and venous separation functionality in order to facilitate the diagnosis of vascular disease. In addition, the Company is the sole distributor of Machnet breast biopsy intervention devices and magnetic resonance breast and carotid coils.
More information about the Company or its technology can be obtained by visiting our website at http://www.cadsciences.com or by calling our office at 877-387-4387.
Media Contacts: Raymond E. Joslin, 914-313-0330, raymond.joslin@cadsciences.com Nancy Isenberger, 212-818-1894, nancy.isenberger@cadsciences.com About Hitachi Medical Systems America, Inc.:
Hitachi Medical Systems America, Inc. markets premium and high performance magnetic resonance imaging systems of Hitachi Medical Corporation, Tokyo, Japan. These include the AIRIS(R) Elite advanced mid-field open MR system, the Altaire high-field performance MR system and the AIRIS(R) II MR system. The company has more than 1,500 Open Magnetic Resonance Imaging systems installed throughout the United States and over 3,100 Open MRI systems installed worldwide. HMSA first established a leadership position in the medical industry with Open MRI systems and has expanded their modality offerings to include computed tomography, ultrasound, PET/CT, optical topography, and 3D dental imaging. For more information about HMSA's complete line of imaging products and services, please visit http://www.hitachimed.com.
Hitachi, Ltd. , headquartered in Tokyo, Japan, is a leading global electronics company, with approximately 347,000 employees worldwide. Fiscal 2004 (ended March 31, 2005) consolidated sales totaled 9,027.0 billion yen ($84.4 billion). The company offers a wide range of systems, products and services in market sectors, including information systems, electronic devices, power and industrial systems, medical imaging equipment, consumer products, materials and financial services.
For more information about the advanced breast imaging capabilities of the Altaire(R) High-Performance Open MR system, contact your local Hitachi representative or log onto http://www.hitachimed.com.
Media contact:
Phil Chang, Marketing Communications Manager, 330-425 1313,
changp@hitachimed.com
CAD SciencesCONTACT: Raymond E. Joslin, +1-914-313-0330,raymond.joslin@cadsciences.com, or Nancy Isenberger, +1-212-818-1894,nancy.isenbergeri@cadsciences.com, both of CAD Sciences; or Phil Chang ofHitachi Medical Systems America, Inc., +1-330-425 1313,changp@hitachimed.com
